This kit is intended to in vitro qualitative detection of novel coronavirus (SARS- CoV-2) in nasopharyngeal and oropharyngeal swab samples. RNA from SARS-CoV-2 is generally detectable in respiratory specimens during the acute phase of infection or asymptomatic people. It can be used further qualitative detection and differentiation of Alpha, Beta, Gamma, Delta and Omicron.
Epidemiology
The novel coronavirus (SARS-CoV-2) has spread on a large scale around the world. In the process of dissemination, new mutations constantly occur, resulting in new variants. This product is mainly used for the auxiliary detection and differentiation of cases related to infection after the large-scale spread of Alpha, Beta, Gamma, Delta and Omicron mutant strains since December 2020.
Technical Parameters
Storage
≤-18℃ In dark
Shelf-life
9 months
CV
≤5.0%
Ct
≤38
LoD
1000Copies/mL
Specificity
There is no cross-reactivity with human coronaviruses SARS-CoV and other common pathogens.
Applicable Instruments:
QuantStudio™5 Real-Time PCR Systems
SLAN ®-96P Real-Time PCR Systems
LightCycler®480 Real-Time PCR system
LineGene 9600 Plus Real-Time PCR Detection System
MA-6000 Real-Time Quantitative Thermal Cycler
BioRad CFX96 Real-Time PCR System
BioRad CFX Opus 96 Real-Time PCR System